BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Boehringer Ingelheim
Express Scripts
US Army
Fish and Richardson
Daiichi Sankyo

Generated: November 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020928

« Back to Dashboard
NDA 020928 describes GLUCAGON, which is a drug marketed by Lilly and Fresenius Kabi Usa and is included in three NDAs. It is available from four suppliers. Additional details are available on the GLUCAGON profile page.

The generic ingredient in GLUCAGON is glucagon recombinant. There are eleven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the glucagon recombinant profile page.

Summary for 020928

Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 020928

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
glucagon recombinant
INJECTABLE;INJECTION 020928 NDA Eli Lilly and Company 0002-8031 0002-8031-01 1 KIT in 1 KIT (0002-8031-01) * 1 mL in 1 VIAL (0002-7529-01) * 1 mL in 1 SYRINGE (0002-7530-01)
glucagon recombinant
INJECTABLE;INJECTION 020928 NDA Physicians Total Care, Inc. 54868-5070 54868-5070-0 1 KIT in 1 KIT * 1 mL in 1 VIAL * 1 mL in 1 SYRINGE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength1MG/VIAL
Approval Date:Sep 11, 1998TE:RLD:Yes

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Daiichi Sankyo
Express Scripts
US Department of Justice
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus